🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, controlled, multicenter clinical study that enrolled ...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-05-01
Trial ID
NCT07560358
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
Early-onset preeclampsia (PE), defined as preeclampsia presenting before 34...
Status
Not Yet Recruiting
Location
Hadassah University Medical Center
Start Date
2026-09
Trial ID
NCT07738562
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of induction the...
Status
Completed
Location
Duke University Medical Center
Start Date
2008-08
Trial ID
NCT00691704
Treatments Being Tested
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
The purpose of this study is to evaluate the effectiveness and tolerability...
Status
Completed
Location
Advanced Medical Specialties
Start Date
2005-11
Trial ID
NCT00270894
Treatments Being Tested
This is an open-label, single arm Phase II study designed to observe and ev...
Status
Unknown
Location
HenanCH
Start Date
2023-12-01
Trial ID
NCT06586697
Treatments Being Tested
We have designed a single-arm, open-label study of sirolimus in Chinese pat...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2017-09-21
Trial ID
NCT03688191
Treatments Being Tested
Title: The Efficacy, Safety, and PK/PD of Efgartigimod Followed by Telitaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06827587
The purpose of this study is to assess the safety, tolerability and steady-...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT01079351
Treatments Being Tested